Announcements Trials
Browse Landscape

Status

Completed 2Unknown 1

Sponsor Class

OTHER_GOV 1

Study Type

Observational 1

Sponsor

Cancer Type

Sarcoma 1Plasma cell 1Breast 1

Conditions

Multiple Myeloma 339Neoplasms, Plasma Cell 62Lymphoma 38Recurrence 27Leukemia 26Lymphoma, Non-Hodgkin 21Leukemia, Myeloid, Acute 20Hodgkin Disease 19Precursor Cell Lymphoblastic Leukemia-Lymphoma 18Myelodysplastic Syndromes 17Leukemia, Lymphocytic, Chronic, B-Cell 17Lymphoma, Follicular 16Lymphoma, Large B-Cell, Diffuse 15Immunoglobulin Light-chain Amyloidosis 14Lymphoma, B-Cell, Marginal Zone 13Hematologic Neoplasms 13Lymphoma, Mantle-Cell 12Burkitt Lymphoma 12Lymphoma, Large-Cell, Immunoblastic 10Neoplasms 8Myeloproliferative Disorders 8Leukemia, Myeloid, Chronic-Phase 8Leukemia, Myeloid, Accelerated Phase 8Blast Crisis 8Neoplasm, Residual 7Hematologic Diseases 7Pancreatic Neoplasms 6Lymphoma, T-Cell, Cutaneous 6Lymphoma, B-Cell 6Lung Neoplasms 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Fractures, Spontaneous × Plasma cell × Clear all
NCT04364724 2020-04-28

CTFEA Myeloma Study

Tel-Aviv Sourasky Medical Center

Unknown
200 enrolled
Plasma cellSarcoma

Bone Neoplasms, Fractures, Spontaneous, Multiple Myeloma, Disease Progression

Data powered by HemOnc (CC BY 4.0) Colophon âš¡